Dose level response rates of mTOR inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)
* Therapeutic dose of mTOR inhibitor is effective in shrinking TSC related SEGAs. Doses less than 2.5 mg/m2 were insufficient to maintain response in this limited series.